Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Pharmacy teams ‘uniquely’ placed to offer advice alongside heartburn products, GSK says

Pharmacists and their teams can support those suffering from heartburn and acid reflux with advice and products, Nexium Control manufacturer GSK has said.

Nexium Control – which contains the active ingredient esomeprazole – is a short-term treatment for reflux symptoms, including heartburn and acid regurgitation, in adults, GSK explained.

Citing 2022 research from NielsenIQ, Nexium Control is Great Britain’s leading 24-hour heartburn protection product, the manufacturer claimed, but pharmacy teams can provide more effective treatment for patients by providing advice alongside the product, GSK said.

“Pharmacy teams play an important role in frontline management of frequent heartburn…on account of their unique and trusted position,” GSK expert marketing executive for Nexium Control Devika Dileepkumar said.

GSK “recognises that we have a responsibility to continue providing pharmacists and their teams with the support and guidance to help their patients in providing long-lasting protection for frequent heartburn”, Ms Dileepkumar added.

Pharmacy teams can access product information and advice on GSK’s Health Partner portal, while Nexium Control products retail at:

  • £7.49 for one seven-tablet pack
  • £12.99 for one 14-tablet pack
  • £13.99 for one 14-capsule pack.

To order, call the telesales team on 0203 044 8640

 

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD136207

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel